Financial Gravity Asset Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Financial Gravity Asset Management’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3	Closed	-$3K	–	1397
2019 Q4	$3K	Hold	3	–	–	﹤0.01%	1321
2019 Q3	$0	Hold	3	–	–	﹤0.01%	1603
2019 Q2	$0	Hold	3	–	–	﹤0.01%	1725
2019 Q1	$0	Buy	+3	New	+$45	﹤0.01%	1579
2018 Q3	$0	Hold	3	–	–	﹤0.01%	1661
2018 Q2	$0	Hold	3	–	–	﹤0.01%	1645
2018 Q1	$0	Buy	+3	New	+$213	﹤0.01%	1523

Other funds holding LUMO

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

IFG

Investors Financial Group Plymouth, Minnesota $215M AUM 19.81% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Financial Gravity Asset Management's LUMO Position: Q1 2020 in Review

Financial Gravity Asset Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2020, closing a stake of 3 shares — an estimated $3K sold.

Financial Gravity Asset Management first reported a position in LUMO in Q1 2018 and held it in 7 quarters. The position peaked at $3K in Q4 2019. 46 funds tracked by Wall St. Rank hold LUMO as of Q1 2020.

Financial Gravity Asset Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Financial Gravity Asset Management sold 3 Lumos Pharma, Inc. Common Stock shares in Q1 2020, an estimated $3K.
Financial Gravity Asset Management first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2018 and held it in 7 quarters.
Financial Gravity Asset Management's Lumos Pharma, Inc. Common Stock position peaked at $3K in Q4 2019.
46 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2020.

Based on Financial Gravity Asset Management's 13F filing for Q1 2020, filed 12 May 2020.